We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+15.99%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.57B
AUM Growth
+$240M
Cap. Flow
-$1.33M
Cap. Flow %
-0.05%
Top 10 Hldgs %
34.11%
Holding
1,211
New
84
Increased
525
Reduced
539
Closed
63

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$18.8M
2
LIN icon
Linde
LIN
+$15.3M
3
AVGO icon
Broadcom
AVGO
+$2.95M
4
AMD icon
Advanced Micro Devices
AMD
+$2.59M
5
HD icon
Home Depot
HD
+$1.46M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$6.03M
2
MSFT icon
Microsoft
MSFT
+$5.38M
3
CVX icon
Chevron
CVX
+$4.36M
4
META icon
Meta Platforms (Facebook)
META
+$4.08M
5
AAPL icon
Apple
AAPL
+$3.64M

Sector Composition

Rank Sector Weight
1 Technology 42.5%
2 Healthcare 12.67%
3 Consumer Discretionary 11.07%
4 Communication Services 9.14%
5 Financials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCG icon
276
PG&E
PCG
$47.8B
$1.33M 0.05%
79,622
-6,625
-8% -$111K
NTLA icon
277
Intellia Therapeutics
NTLA
$1.5B
$1.33M 0.05%
48,300
-2,676
-5% -$74.3K
APLS
278
DELISTED
Apellis Pharmaceuticals
APLS
$1.32M 0.05%
22,533
-25
-0.1% -$1.59K
KYMR icon
279
Kymera Therapeutics
KYMR
$9.1B
$1.32M 0.05%
32,825
+12,938
+65% +$463K
ZTO icon
280
ZTO Express
ZTO
$18.2B
$1.32M 0.05%
62,936
-4,794
-7% -$91.7K
ENPH icon
281
Enphase Energy
ENPH
$4.84B
$1.32M 0.05%
10,876
+1,518
+16% +$177K
TWST icon
282
Twist Bioscience
TWST
$5.62B
$1.31M 0.05%
38,230
+616
+2% +$22.2K
PBR.A icon
283
Petrobras Class A
PBR.A
$107B
$1.31M 0.05%
87,748
-15,278
-15% -$241K
TGTX icon
284
TG Therapeutics
TGTX
$8.58B
$1.3M 0.05%
85,796
-7,693
-8% -$123K
DOW icon
285
Dow Inc
DOW
$21.6B
$1.3M 0.05%
22,517
-1,456
-6% -$80.5K
HLT icon
286
Hilton Worldwide
HLT
$74B
$1.29M 0.05%
6,067
+605
+11% +$119K
NUE icon
287
Nucor
NUE
$56.4B
$1.29M 0.05%
6,530
+79
+1% +$14.4K
AZO icon
288
AutoZone
AZO
$48.3B
$1.29M 0.05%
410
+25
+6% +$71.5K
ENTG icon
289
Entegris
ENTG
$19.7B
$1.28M 0.05%
9,134
+1,970
+27% +$252K
RARE icon
290
Ultragenyx Pharmaceutical
RARE
$2.65B
$1.28M 0.05%
27,484
-7,531
-22% -$355K
ITUB icon
291
Itaú Unibanco
ITUB
$91.3B
$1.28M 0.05%
209,750
-36,525
-15% -$220K
WM icon
292
Waste Management
WM
$95.9B
$1.28M 0.05%
6,007
+1,120
+23% +$220K
NUVL
293
DELISTED
Nuvalent
NUVL
$1.28M 0.05%
17,039
-3,656
-18% -$291K
CPRX
294
DELISTED
Catalyst Pharmaceutical
CPRX
$1.28M 0.05%
80,142
+18,578
+30% +$280K
BEAM icon
295
Beam Therapeutics
BEAM
$2.58B
$1.28M 0.05%
38,636
-16,730
-30% -$521K
CLDX icon
296
Celldex Therapeutics
CLDX
$2.77B
$1.27M 0.05%
30,347
+5,861
+24% +$241K
SNAP icon
297
Snap
SNAP
$7.32B
$1.27M 0.05%
110,698
+24,200
+28% +$324K
RXRX icon
298
Recursion Pharmaceuticals
RXRX
$1.57B
$1.27M 0.05%
127,156
-35,469
-22% -$395K
ARQT icon
299
Arcutis Biotherapeutics
ARQT
$3.42B
$1.25M 0.05%
+126,283
New +$942K
GERN icon
300
Geron
GERN
$911M
$1.24M 0.05%
376,360
+100,537
+36% +$225K
10 11
12
13 14

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Profund Advisors held 1,211 positions worth $2.57B, up 10% from $2.33B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors's Q1 2024 filing shows 84 new, 525 increased, 539 reduced and 63 closed positions. Its largest new stake was Altimmune: 134,842 shares worth $1.37M. The largest sale was ExxonMobil, an estimated $6.03M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Profund Advisors's largest Q1 2024 buy was Altimmune: 134,842 shares worth $1.37M.
  • Profund Advisors added most to NVIDIA in Q1 2024, an estimated $18.8M increase.
  • Profund Advisors's biggest Q1 2024 reduction was ExxonMobil, cutting an estimated $6.03M.
  • Profund Advisors fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $2.18M.
  • Profund Advisors's ten largest holdings make up 34% of its $2.57B portfolio in Q1 2024.
  • Profund Advisors opened 84 new positions and closed 63 in Q1 2024.
  • Profund Advisors's portfolio value rose 10% quarter-over-quarter to $2.57B.

Based on Profund Advisors's 13F filing for Q1 2024, filed 8 May 2024.